| |
| |
| Signup for the #JPM24 daily updates and stay informed about the newest deals, M&A announcements, industry trends, conference highlights, and much more. |
|
| |
| |
| |
#JPM24 is finally here! Have you registered to receive daily updates?
Our dedicated team will be on-site, bringing you daily coverage of all the crucial news and announcements.
Signup today and we'll deliver the updates straight to your inbox.
Here's what to expect...
|
|
| |
| |
| A daily recap of the highlights and key developments unveiled in company presentations. |
|
| | Full list of events and catalysts which were announced or updated on the day | | | Highlights from company presentations including large, mid and small cap biopharma |
|
|
| |
| |
| |
| A look ahead at some of the most exciting innovations that are shaping the industry. |
|
| | Artificial intelligence (AI), the metaverse and other digital applications | | | See the developments that are delivering better patient outcomes |
|
|
| |
| |
| |
| Access the most powerful, comprehensive view of the year to come. |
|
| | Key influences, deals, policies and therapies shaping 2024 and beyond | | | The latest and greatest across pharma, biotech, medtech and generics |
|
|
| |
| |
| | JP Morgan Preview Report
Our expert team picks on who to watch at JPM2024 | | | Tech and Trends E-book
The biopharmaceutical markets and the developments that matter | | | Outlook Extract 2024
The most comprehensive view of the year to come | | | JP Morgan Post Report Extract
Get our full conference report from the JPM2024 conference |
|
|
| |
This email was sent from Citeline Commercial
Citeline 2024 | |
|
